What You Should Know:
– Canary Speech, Inc. (Canary), a pioneer in AI-powered voice biomarker technology, announced today it has closed a $13M Series A funding round.
– The round was led by Cortes Capital, LLC (Love’s Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health.
Canary’s Cutting-Edge Technology
Canary Speech leverages vocal analysis to identify early signs of mental health and neurological conditions. Their patented technology analyzes speech data within seconds, detecting subtle vocal changes that may precede typical clinical symptoms of conditions like anxiety, depression, and dementia. This enables proactive intervention and improved patient outcomes.
Applications Transforming Patient Care
Canary’s API-first approach offers a versatile platform with multiple applications within healthcare:
- Contact centers: Canary helps assess caller well-being during interactions.
- Ambient clinical listening: Canary enhances this technology by providing real-time behavioral and cognitive screening, offering crucial data to providers.
- Remote patient monitoring: Allows for ongoing monitoring and early detection of potential healthcare issues.
- Annual wellness checks: Canary’s technology can be integrated into routine checkups for a more comprehensive assessment.
Beyond Patient Care: Supporting Healthcare Professionals
Canary’s technology extends its reach to support healthcare professionals facing burnout. By analyzing physicians’ voices during patient interactions, Canary can identify potential burnout symptoms, allowing healthcare systems to proactively support their staff.
Funding Fuels Growth and Innovation
This funding round empowers Canary to:
- Expand its team: Recruit top talent to accelerate growth driven by AI advancements and healthcare’s demand for advanced tools.
- Scale its cloud-based platform: Canary leverages a vast partnership network to rapidly scale its data processing capabilities, serving a wider range of healthcare applications.
“There are technologies that truly disrupt the way healthcare is administered, and Canary is committed to pioneering vocal biomarkers and ambient listening for the betterment of healthcare,” said Henry O’Connell, co-founder and CEO of Canary Speech.